First Quadrant’s Zimmer Biomet ZBH Stock Holding History

First Quadrant’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-8,240	Closed	-$751K	–	849
2015 Q3	$751K	Sell	8,240 -31,312	-79%	-$3.14M	0.02%	406
2015 Q2	$4.19M	Sell	39,552 -199,202	-83%	-$22M	0.09%	216
2015 Q1	$27.2M	Buy	238,754 +229,896	+2,595%	+$26.2M	0.57%	55
2014 Q4	$975K	Hold	8,858	–	–	0.02%	357
2014 Q3	$865K	Hold	8,858	–	–	0.02%	380
2014 Q2	$893K	Hold	8,858	–	–	0.02%	403
2014 Q1	$813K	Sell	8,858 -108,047	-92%	-$9.96M	0.02%	395
2013 Q4	$10.6M	Sell	116,905 -46,453	-28%	-$4.02M	0.25%	118
2013 Q3	$13M	Hold	163,358	–	–	0.33%	94
2013 Q2	$11.9M	Buy	+163,358	New	+$12.2M	0.32%	90

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Quadrant's ZBH Position: Q4 2015 in Review

First Quadrant sold out of Zimmer Biomet (ZBH) in Q4 2015, closing a stake of 8,240 shares — an estimated $751K sold.

First Quadrant first reported a position in ZBH in Q2 2013 and held it in 10 quarters. The position peaked at $27.2M in Q1 2015. 739 funds tracked by Wall St. Rank hold ZBH as of Q4 2015.

First Quadrant reported no remaining Zimmer Biomet position as of Q4 2015 after selling out during the quarter.
First Quadrant sold 8,240 Zimmer Biomet shares in Q4 2015, an estimated $751K.
First Quadrant first reported a position in Zimmer Biomet in Q2 2013 and held it in 10 quarters.
First Quadrant's Zimmer Biomet position peaked at $27.2M in Q1 2015.
739 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2015.

Based on First Quadrant's 13F filing for Q4 2015, filed 26 Jan 2016.